Shape engineering boosts antibacterial activity of chitosan coated mesoporous silica nanoparticle doped with silver: a mechanistic investigation.
暂无分享,去创建一个
P. Chakrabarti | M. Odén | J. Rosenholm | S. Chakraborti | S. Sarwar | D. Şen Karaman | P Chakrabarti | D Şen Karaman | S Sarwar | D Desai | E M Björk | M Odén | J M Rosenholm | S Chakraborti | E. Björk | D. Desai
[1] Yong-Kweon Kim,et al. Surface-enhanced Raman scattering-active nanostructures and strategies for bioassays. , 2011, Nanomedicine.
[2] J. Song,et al. Does the Antibacterial Activity of Silver Nanoparticles Depend on the Shape of the Nanoparticle? A Study of the Gram-Negative Bacterium Escherichia coli , 2007, Applied and Environmental Microbiology.
[3] A. Bakillah,et al. Nutrition & Metabolism: an impressive performance since inception , 2013, Nutrition & Metabolism.
[4] Jianlin Shi,et al. Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility , 2011 .
[5] K. Pavelić,et al. Biological and therapeutic effects of ortho-silicic acid and some ortho-silicic acid-releasing compounds: New perspectives for therapy , 2013, Nutrition & Metabolism.
[6] H. Umezawa,et al. Resistance mechanisms of kanamycin-, neomycin-, and streptomycin-producing streptomycetes to aminoglycoside antibiotics. , 1981, The Journal of antibiotics.
[7] S. Faruque,et al. Epidemiology, Genetics, and Ecology of ToxigenicVibrio cholerae , 1998, Microbiology and Molecular Biology Reviews.
[8] S. Bhoraskar,et al. Antimicrobial activity of silica coated silicon nano-tubes (SCSNT) and silica coated silicon nano-particles (SCSNP) synthesized by gas phase condensation , 2013, Journal of Materials Science: Materials in Medicine.
[9] Thomas J Webster,et al. Antimicrobial applications of nanotechnology: methods and literature , 2012, International journal of nanomedicine.
[10] Albert Duschl,et al. Hardening of the nanoparticle-protein corona in metal (Au, Ag) and oxide (Fe3O4, CoO, and CeO2) nanoparticles. , 2011, Small.
[11] Frederico J. Gueiros-Filho,et al. FtsZ filament capping by MciZ, a developmental regulator of bacterial division , 2015, Proceedings of the National Academy of Sciences.
[12] Slobodan Ilic,et al. Nutrition/Metabolism , 2011, Intensive Care Medicine.
[13] O. Assis,et al. A Review of the Antimicrobial Activity of Chitosan , 2009 .
[14] N. Prabhakar,et al. Design considerations for mesoporous silica nanoparticulate systems in facilitating biomedical applications , 2014 .
[15] M. Odén,et al. Tuning the shape of mesoporous silica particles by alterations in parameter space: from rods to platelets. , 2013, Langmuir : the ACS journal of surfaces and colloids.
[16] P. Chakrabarti,et al. Bactericidal effect of polyethyleneimine capped ZnO nanoparticles on multiple antibiotic resistant bacteria harboring genes of high-pathogenicity island. , 2014, Colloids and surfaces. B, Biointerfaces.
[17] Yumin Du,et al. Chitosan- metal complexes as antimicrobial agent: Synthesis, characterization and Structure-activity study , 2005 .
[18] U. Pal,et al. Effects of crystallization and dopant concentration on the emission behavior of TiO2:Eu nanophosphors , 2012, Nanoscale Research Letters.
[19] Adam J Friedman,et al. Nanotechnology as a therapeutic tool to combat microbial resistance. , 2013, Advanced drug delivery reviews.
[20] P. Stewart,et al. Transmission Electron Microscopic Study of Antibiotic Action on Klebsiella pneumoniae Biofilm , 2002, Antimicrobial Agents and Chemotherapy.
[21] Deborah Berhanu,et al. The complexity of nanoparticle dissolution and its importance in nanotoxicological studies. , 2012, The Science of the total environment.
[22] Ashutosh Kumar,et al. Engineered ZnO and TiO(2) nanoparticles induce oxidative stress and DNA damage leading to reduced viability of Escherichia coli. , 2011, Free radical biology & medicine.
[23] S. Mukherjee,et al. CdO nanoparticle toxicity on growth, morphology, and cell division in Escherichia coli. , 2012, Langmuir : the ACS journal of surfaces and colloids.
[24] K. Jeyasubramanian,et al. Selective toxicity of ZnO nanoparticles toward Gram-positive bacteria and cancer cells by apoptosis through lipid peroxidation. , 2011, Nanomedicine : nanotechnology, biology, and medicine.
[25] Chun-Ming Huang,et al. Development of nanoparticles for antimicrobial drug delivery. , 2010, Current medicinal chemistry.
[26] C. Hauser,et al. In situ synthesis of size-controlled, stable silver nanoparticles within ultrashort peptide hydrogels and their anti-bacterial properties. , 2014, Biomaterials.
[27] Y. Berger,et al. The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications , 1995, Cell Biology and Toxicology.
[28] Anders Baun,et al. The challenges of testing metal and metal oxide nanoparticles in algal bioassays: titanium dioxide and gold nanoparticles as case studies , 2012, Nanotoxicology.
[29] Kevin W Eliceiri,et al. NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.
[30] R. D'ari,et al. Selected amplification of the cell division genes ftsQ-ftsA-ftsZ in Escherichia coli. , 2000, Genetics.
[31] G. Alangaden,et al. Mechanism of Resistance to Amikacin and Kanamycin in Mycobacterium tuberculosis , 1998, Antimicrobial Agents and Chemotherapy.
[32] K. Ahmed,et al. Copper nanoparticles as an efflux pump inhibitor to tackle drug resistant bacteria , 2015 .
[33] P. Ducheyne,et al. Polymer-coated mesoporous silica nanoparticles for the controlled release of macromolecules. , 2012, Acta biomaterialia.
[34] J. Trevors,et al. Cytoplasmic membrane polarization in Gram-positive and Gram-negative bacteria grown in the absence and presence of tetracycline. , 2004, Biochimica et biophysica acta.
[35] M. B. Cardoso,et al. Tailored silica-antibiotic nanoparticles: overcoming bacterial resistance with low cytotoxicity. , 2014, Langmuir : the ACS journal of surfaces and colloids.
[36] J. M. Córdoba,et al. Rapid synthesis of SBA-15 rods with variable lengths, widths, and tunable large pores. , 2011, Langmuir : the ACS journal of surfaces and colloids.
[37] H. Gu,et al. Modulation of the structural properties of mesoporous silica nanoparticles to enhance the T1-weighted MR imaging capability. , 2016, Journal of materials chemistry. B.
[38] Juan L. Vivero-Escoto,et al. Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells. , 2009, Small.
[39] Erik N. Taylor,et al. Reducing infections through nanotechnology and nanoparticles , 2011, International journal of nanomedicine.
[40] Muhammad Ilyas,et al. Impact of nanoparticles on human and environment: review of toxicity factors, exposures, control strategies, and future prospects , 2015, Environmental Science and Pollution Research.
[41] J. Jang,et al. Enhanced antibacterial activity of silver/polyrhodanine-composite-decorated silica nanoparticles. , 2013, ACS applied materials & interfaces.
[42] P. Chakrabarti,et al. The Molecular Basis of Inactivation of Metronidazole-Resistant Helicobacter pylori Using Polyethyleneimine Functionalized Zinc Oxide Nanoparticles , 2013, PloS one.
[43] H. Sahl,et al. Insights into the Mode of Action of Chitosan as an Antibacterial Compound , 2008, Applied and Environmental Microbiology.
[44] I. Sondi,et al. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. , 2004, Journal of colloid and interface science.
[45] Bengt Fadeel,et al. Size-dependent cytotoxicity of silver nanoparticles in human lung cells: the role of cellular uptake, agglomeration and Ag release , 2014, Particle and Fibre Toxicology.
[46] P. Eklund,et al. Rational evaluation of the utilization of PEG-PEI copolymers for the facilitation of silica nanoparticulate systems in biomedical applications. , 2014, Journal of colloid and interface science.
[47] J. Costerton,et al. Evaluation of Fleroxacin Activity against Established Pseudomonas fluorescens Biofilms , 1994, Applied and environmental microbiology.
[48] Z. Guan,et al. The Outer Surface Lipoprotein VolA Mediates Utilization of Exogenous Lipids by Vibrio cholerae , 2013, mBio.
[49] P. Chakrabarti,et al. The antimicrobial activity of ZnO nanoparticles against Vibrio cholerae: Variation in response depends on biotype. , 2016, Nanomedicine : nanotechnology, biology, and medicine.
[50] Linlin Li,et al. Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery , 2012, Advanced materials.
[51] J. Zink,et al. Antimicrobial Activity of Silver Nanocrystals Encapsulated in Mesoporous Silica Nanoparticles , 2009 .
[52] Wojciech Zareba,et al. Ambient fine particulate air pollution triggers ST-elevation myocardial infarction, but not non-ST elevation myocardial infarction: a case-crossover study , 2014, Particle and Fibre Toxicology.
[53] H. Sahl,et al. Antibiotic acyldepsipeptides activate ClpP peptidase to degrade the cell division protein FtsZ , 2011, Proceedings of the National Academy of Sciences.
[54] J. Collins,et al. Dinuclear ruthenium(II) antimicrobial agents that selectively target polysomes in vivo , 2014 .
[55] Y. Hwang,et al. Photoluminescence characteristics of Cd1-xMnxTe single crystals grown by the vertical Bridgman method , 2012, Nanoscale Research Letters.
[56] Mark A. Miller,et al. Enteric infections, diarrhea, and their impact on function and development. , 2008, The Journal of clinical investigation.
[57] T. Xia,et al. Understanding biophysicochemical interactions at the nano-bio interface. , 2009, Nature materials.
[58] D. Scherman,et al. Mesoporous persistent nanophosphors for in vivo optical bioimaging and drug-delivery. , 2014, Nanoscale.
[59] R. Iler. The Chemistry of Silica: Solubility, Polymerization, Colloid and Surface Properties and Biochemistry of Silica , 1979 .
[60] Didem Şen Karaman,et al. Targeted delivery of a novel anticancer compound anisomelic acid using chitosan-coated porous silica nanorods for enhancing the apoptotic effect. , 2015, Biomaterials science.
[61] Ruchira Chakraborty,et al. A simple robust method for synthesis of metallic copper nanoparticles of high antibacterial potency against E. coli , 2012, Nanotechnology.
[62] ScienceDirect. Nanomedicine : nanotechnology, biology and medicine. , 2005 .
[63] Young Jik Kwon,et al. "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[64] F. Corona,et al. The intrinsic resistome of bacterial pathogens , 2013, Front. Microbiol..
[65] W. D. de Jong,et al. Drug delivery and nanoparticles: Applications and hazards , 2008, International journal of nanomedicine.
[66] Sanath H. Kumar,et al. Potential for inhibition of bacterial efflux pumps in multidrug-resistant Vibrio cholera , 2013, The Indian journal of medical research.
[67] H. Santos,et al. Mesoporous Biomaterials – multifunctional materials for future medical therapies and bioanalysis , 2015 .
[68] L. Rice. The clinical consequences of antimicrobial resistance. , 2009, Current opinion in microbiology.